0
     

Report Added
Report already added
Antihemophilic Factor Market - Global Outlook and Forecast 2022-2028

Antihemophilic Factor Market - Global Outlook and Forecast 2022-2028

This report contains market size and forecasts of Antihemophilic Factor in global, including the following market information:

Global Antihemophilic Factor Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Antihemophilic Factor Market Sales, 2017-2022, 2023-2028, (Kiloton)
Global top five Antihemophilic Factor companies in 2021 (%)
The global Antihemophilic Factor market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Powder Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antihemophilic Factor include Biogen Idec, Bayer, Octapharma, Novo Nordisk, Baxter, Genetics Institute and Wyeth Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antihemophilic Factor manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:
Global Antihemophilic Factor Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Antihemophilic Factor Market Segment Percentages, by Type, 2021 (%)
Powder
Liquid
Global Antihemophilic Factor Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Antihemophilic Factor Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Global Antihemophilic Factor Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Antihemophilic Factor Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antihemophilic Factor revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Antihemophilic Factor revenues share in global market, 2021 (%)
Key companies Antihemophilic Factor sales in global market, 2017-2022 (Estimated), (Kiloton)
Key companies Antihemophilic Factor sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biogen Idec
Bayer
Octapharma
Novo Nordisk
Baxter
Genetics Institute
Wyeth Pharmaceuticals
Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Antihemophilic Factor Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antihemophilic Factor Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antihemophilic Factor Overall Market Size
2.1 Global Antihemophilic Factor Market Size: 2021 VS 2028
2.2 Global Antihemophilic Factor Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Antihemophilic Factor Sales: 2017-2028
3 Company Landscape
3.1 Top Antihemophilic Factor Players in Global Market
3.2 Top Global Antihemophilic Factor Companies Ranked by Revenue
3.3 Global Antihemophilic Factor Revenue by Companies
3.4 Global Antihemophilic Factor Sales by Companies
3.5 Global Antihemophilic Factor Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Antihemophilic Factor Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Antihemophilic Factor Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antihemophilic Factor Players in Global Market
3.8.1 List of Global Tier 1 Antihemophilic Factor Companies
3.8.2 List of Global Tier 2 and Tier 3 Antihemophilic Factor Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Antihemophilic Factor Market Size Markets, 2021 & 2028
4.1.2 Powder
4.1.3 Liquid
4.2 By Type - Global Antihemophilic Factor Revenue & Forecasts
4.2.1 By Type - Global Antihemophilic Factor Revenue, 2017-2022
4.2.2 By Type - Global Antihemophilic Factor Revenue, 2023-2028
4.2.3 By Type - Global Antihemophilic Factor Revenue Market Share, 2017-2028
4.3 By Type - Global Antihemophilic Factor Sales & Forecasts
4.3.1 By Type - Global Antihemophilic Factor Sales, 2017-2022
4.3.2 By Type - Global Antihemophilic Factor Sales, 2023-2028
4.3.3 By Type - Global Antihemophilic Factor Sales Market Share, 2017-2028
4.4 By Type - Global Antihemophilic Factor Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Antihemophilic Factor Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Antihemophilic Factor Revenue & Forecasts
5.2.1 By Application - Global Antihemophilic Factor Revenue, 2017-2022
5.2.2 By Application - Global Antihemophilic Factor Revenue, 2023-2028
5.2.3 By Application - Global Antihemophilic Factor Revenue Market Share, 2017-2028
5.3 By Application - Global Antihemophilic Factor Sales & Forecasts
5.3.1 By Application - Global Antihemophilic Factor Sales, 2017-2022
5.3.2 By Application - Global Antihemophilic Factor Sales, 2023-2028
5.3.3 By Application - Global Antihemophilic Factor Sales Market Share, 2017-2028
5.4 By Application - Global Antihemophilic Factor Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Antihemophilic Factor Market Size, 2021 & 2028
6.2 By Region - Global Antihemophilic Factor Revenue & Forecasts
6.2.1 By Region - Global Antihemophilic Factor Revenue, 2017-2022
6.2.2 By Region - Global Antihemophilic Factor Revenue, 2023-2028
6.2.3 By Region - Global Antihemophilic Factor Revenue Market Share, 2017-2028
6.3 By Region - Global Antihemophilic Factor Sales & Forecasts
6.3.1 By Region - Global Antihemophilic Factor Sales, 2017-2022
6.3.2 By Region - Global Antihemophilic Factor Sales, 2023-2028
6.3.3 By Region - Global Antihemophilic Factor Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Antihemophilic Factor Revenue, 2017-2028
6.4.2 By Country - North America Antihemophilic Factor Sales, 2017-2028
6.4.3 US Antihemophilic Factor Market Size, 2017-2028
6.4.4 Canada Antihemophilic Factor Market Size, 2017-2028
6.4.5 Mexico Antihemophilic Factor Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Antihemophilic Factor Revenue, 2017-2028
6.5.2 By Country - Europe Antihemophilic Factor Sales, 2017-2028
6.5.3 Germany Antihemophilic Factor Market Size, 2017-2028
6.5.4 France Antihemophilic Factor Market Size, 2017-2028
6.5.5 U.K. Antihemophilic Factor Market Size, 2017-2028
6.5.6 Italy Antihemophilic Factor Market Size, 2017-2028
6.5.7 Russia Antihemophilic Factor Market Size, 2017-2028
6.5.8 Nordic Countries Antihemophilic Factor Market Size, 2017-2028
6.5.9 Benelux Antihemophilic Factor Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Antihemophilic Factor Revenue, 2017-2028
6.6.2 By Region - Asia Antihemophilic Factor Sales, 2017-2028
6.6.3 China Antihemophilic Factor Market Size, 2017-2028
6.6.4 Japan Antihemophilic Factor Market Size, 2017-2028
6.6.5 South Korea Antihemophilic Factor Market Size, 2017-2028
6.6.6 Southeast Asia Antihemophilic Factor Market Size, 2017-2028
6.6.7 India Antihemophilic Factor Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Antihemophilic Factor Revenue, 2017-2028
6.7.2 By Country - South America Antihemophilic Factor Sales, 2017-2028
6.7.3 Brazil Antihemophilic Factor Market Size, 2017-2028
6.7.4 Argentina Antihemophilic Factor Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Antihemophilic Factor Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Antihemophilic Factor Sales, 2017-2028
6.8.3 Turkey Antihemophilic Factor Market Size, 2017-2028
6.8.4 Israel Antihemophilic Factor Market Size, 2017-2028
6.8.5 Saudi Arabia Antihemophilic Factor Market Size, 2017-2028
6.8.6 UAE Antihemophilic Factor Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Biogen Idec
7.1.1 Biogen Idec Corporate Summary
7.1.2 Biogen Idec Business Overview
7.1.3 Biogen Idec Antihemophilic Factor Major Product Offerings
7.1.4 Biogen Idec Antihemophilic Factor Sales and Revenue in Global (2017-2022)
7.1.5 Biogen Idec Key News
7.2 Bayer
7.2.1 Bayer Corporate Summary
7.2.2 Bayer Business Overview
7.2.3 Bayer Antihemophilic Factor Major Product Offerings
7.2.4 Bayer Antihemophilic Factor Sales and Revenue in Global (2017-2022)
7.2.5 Bayer Key News
7.3 Octapharma
7.3.1 Octapharma Corporate Summary
7.3.2 Octapharma Business Overview
7.3.3 Octapharma Antihemophilic Factor Major Product Offerings
7.3.4 Octapharma Antihemophilic Factor Sales and Revenue in Global (2017-2022)
7.3.5 Octapharma Key News
7.4 Novo Nordisk
7.4.1 Novo Nordisk Corporate Summary
7.4.2 Novo Nordisk Business Overview
7.4.3 Novo Nordisk Antihemophilic Factor Major Product Offerings
7.4.4 Novo Nordisk Antihemophilic Factor Sales and Revenue in Global (2017-2022)
7.4.5 Novo Nordisk Key News
7.5 Baxter
7.5.1 Baxter Corporate Summary
7.5.2 Baxter Business Overview
7.5.3 Baxter Antihemophilic Factor Major Product Offerings
7.5.4 Baxter Antihemophilic Factor Sales and Revenue in Global (2017-2022)
7.5.5 Baxter Key News
7.6 Genetics Institute
7.6.1 Genetics Institute Corporate Summary
7.6.2 Genetics Institute Business Overview
7.6.3 Genetics Institute Antihemophilic Factor Major Product Offerings
7.6.4 Genetics Institute Antihemophilic Factor Sales and Revenue in Global (2017-2022)
7.6.5 Genetics Institute Key News
7.7 Wyeth Pharmaceuticals
7.7.1 Wyeth Pharmaceuticals Corporate Summary
7.7.2 Wyeth Pharmaceuticals Business Overview
7.7.3 Wyeth Pharmaceuticals Antihemophilic Factor Major Product Offerings
7.7.4 Wyeth Pharmaceuticals Antihemophilic Factor Sales and Revenue in Global (2017-2022)
7.7.5 Wyeth Pharmaceuticals Key News
8 Global Antihemophilic Factor Production Capacity, Analysis
8.1 Global Antihemophilic Factor Production Capacity, 2017-2028
8.2 Antihemophilic Factor Production Capacity of Key Manufacturers in Global Market
8.3 Global Antihemophilic Factor Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Antihemophilic Factor Supply Chain Analysis
10.1 Antihemophilic Factor Industry Value Chain
10.2 Antihemophilic Factor Upstream Market
10.3 Antihemophilic Factor Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Antihemophilic Factor Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Antihemophilic Factor in Global Market
Table 2. Top Antihemophilic Factor Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Antihemophilic Factor Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Antihemophilic Factor Revenue Share by Companies, 2017-2022
Table 5. Global Antihemophilic Factor Sales by Companies, (Kiloton), 2017-2022
Table 6. Global Antihemophilic Factor Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Antihemophilic Factor Price (2017-2022) & (US$/Ton)
Table 8. Global Manufacturers Antihemophilic Factor Product Type
Table 9. List of Global Tier 1 Antihemophilic Factor Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antihemophilic Factor Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Antihemophilic Factor Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Antihemophilic Factor Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Antihemophilic Factor Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Antihemophilic Factor Sales (Kiloton), 2017-2022
Table 15. By Type - Global Antihemophilic Factor Sales (Kiloton), 2023-2028
Table 16. By Application – Global Antihemophilic Factor Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Antihemophilic Factor Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Antihemophilic Factor Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Antihemophilic Factor Sales (Kiloton), 2017-2022
Table 20. By Application - Global Antihemophilic Factor Sales (Kiloton), 2023-2028
Table 21. By Region – Global Antihemophilic Factor Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Antihemophilic Factor Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Antihemophilic Factor Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Antihemophilic Factor Sales (Kiloton), 2017-2022
Table 25. By Region - Global Antihemophilic Factor Sales (Kiloton), 2023-2028
Table 26. By Country - North America Antihemophilic Factor Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Antihemophilic Factor Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Antihemophilic Factor Sales, (Kiloton), 2017-2022
Table 29. By Country - North America Antihemophilic Factor Sales, (Kiloton), 2023-2028
Table 30. By Country - Europe Antihemophilic Factor Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Antihemophilic Factor Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Antihemophilic Factor Sales, (Kiloton), 2017-2022
Table 33. By Country - Europe Antihemophilic Factor Sales, (Kiloton), 2023-2028
Table 34. By Region - Asia Antihemophilic Factor Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Antihemophilic Factor Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Antihemophilic Factor Sales, (Kiloton), 2017-2022
Table 37. By Region - Asia Antihemophilic Factor Sales, (Kiloton), 2023-2028
Table 38. By Country - South America Antihemophilic Factor Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Antihemophilic Factor Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Antihemophilic Factor Sales, (Kiloton), 2017-2022
Table 41. By Country - South America Antihemophilic Factor Sales, (Kiloton), 2023-2028
Table 42. By Country - Middle East & Africa Antihemophilic Factor Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Antihemophilic Factor Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Antihemophilic Factor Sales, (Kiloton), 2017-2022
Table 45. By Country - Middle East & Africa Antihemophilic Factor Sales, (Kiloton), 2023-2028
Table 46. Biogen Idec Corporate Summary
Table 47. Biogen Idec Antihemophilic Factor Product Offerings
Table 48. Biogen Idec Antihemophilic Factor Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 49. Bayer Corporate Summary
Table 50. Bayer Antihemophilic Factor Product Offerings
Table 51. Bayer Antihemophilic Factor Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 52. Octapharma Corporate Summary
Table 53. Octapharma Antihemophilic Factor Product Offerings
Table 54. Octapharma Antihemophilic Factor Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 55. Novo Nordisk Corporate Summary
Table 56. Novo Nordisk Antihemophilic Factor Product Offerings
Table 57. Novo Nordisk Antihemophilic Factor Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 58. Baxter Corporate Summary
Table 59. Baxter Antihemophilic Factor Product Offerings
Table 60. Baxter Antihemophilic Factor Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 61. Genetics Institute Corporate Summary
Table 62. Genetics Institute Antihemophilic Factor Product Offerings
Table 63. Genetics Institute Antihemophilic Factor Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 64. Wyeth Pharmaceuticals Corporate Summary
Table 65. Wyeth Pharmaceuticals Antihemophilic Factor Product Offerings
Table 66. Wyeth Pharmaceuticals Antihemophilic Factor Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 67. Antihemophilic Factor Production Capacity (Kiloton) of Key Manufacturers in Global Market, 2020-2022 (Kiloton)
Table 68. Global Antihemophilic Factor Capacity Market Share of Key Manufacturers, 2020-2022
Table 69. Global Antihemophilic Factor Production by Region, 2017-2022 (Kiloton)
Table 70. Global Antihemophilic Factor Production by Region, 2023-2028 (Kiloton)
Table 71. Antihemophilic Factor Market Opportunities & Trends in Global Market
Table 72. Antihemophilic Factor Market Drivers in Global Market
Table 73. Antihemophilic Factor Market Restraints in Global Market
Table 74. Antihemophilic Factor Raw Materials
Table 75. Antihemophilic Factor Raw Materials Suppliers in Global Market
Table 76. Typical Antihemophilic Factor Downstream
Table 77. Antihemophilic Factor Downstream Clients in Global Market
Table 78. Antihemophilic Factor Distributors and Sales Agents in Global Market

List of Figures
Figure 1. Antihemophilic Factor Segment by Type
Figure 2. Antihemophilic Factor Segment by Application
Figure 3. Global Antihemophilic Factor Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Antihemophilic Factor Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Antihemophilic Factor Revenue, 2017-2028 (US$, Mn)
Figure 7. Antihemophilic Factor Sales in Global Market: 2017-2028 (Kiloton)
Figure 8. The Top 3 and 5 Players Market Share by Antihemophilic Factor Revenue in 2021
Figure 9. By Type - Global Antihemophilic Factor Sales Market Share, 2017-2028
Figure 10. By Type - Global Antihemophilic Factor Revenue Market Share, 2017-2028
Figure 11. By Type - Global Antihemophilic Factor Price (US$/Ton), 2017-2028
Figure 12. By Application - Global Antihemophilic Factor Sales Market Share, 2017-2028
Figure 13. By Application - Global Antihemophilic Factor Revenue Market Share, 2017-2028
Figure 14. By Application - Global Antihemophilic Factor Price (US$/Ton), 2017-2028
Figure 15. By Region - Global Antihemophilic Factor Sales Market Share, 2017-2028
Figure 16. By Region - Global Antihemophilic Factor Revenue Market Share, 2017-2028
Figure 17. By Country - North America Antihemophilic Factor Revenue Market Share, 2017-2028
Figure 18. By Country - North America Antihemophilic Factor Sales Market Share, 2017-2028
Figure 19. US Antihemophilic Factor Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Antihemophilic Factor Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Antihemophilic Factor Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Antihemophilic Factor Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Antihemophilic Factor Sales Market Share, 2017-2028
Figure 24. Germany Antihemophilic Factor Revenue, (US$, Mn), 2017-2028
Figure 25. France Antihemophilic Factor Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Antihemophilic Factor Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Antihemophilic Factor Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Antihemophilic Factor Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Antihemophilic Factor Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Antihemophilic Factor Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Antihemophilic Factor Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Antihemophilic Factor Sales Market Share, 2017-2028
Figure 33. China Antihemophilic Factor Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Antihemophilic Factor Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Antihemophilic Factor Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Antihemophilic Factor Revenue, (US$, Mn), 2017-2028
Figure 37. India Antihemophilic Factor Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Antihemophilic Factor Revenue Market Share, 2017-2028
Figure 39. By Country - South America Antihemophilic Factor Sales Market Share, 2017-2028
Figure 40. Brazil Antihemophilic Factor Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Antihemophilic Factor Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Antihemophilic Factor Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Antihemophilic Factor Sales Market Share, 2017-2028
Figure 44. Turkey Antihemophilic Factor Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Antihemophilic Factor Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Antihemophilic Factor Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Antihemophilic Factor Revenue, (US$, Mn), 2017-2028
Figure 48. Global Antihemophilic Factor Production Capacity (Kiloton), 2017-2028
Figure 49. The Percentage of Production Antihemophilic Factor by Region, 2021 VS 2028
Figure 50. Antihemophilic Factor Industry Value Chain
Figure 51. Marketing Channels

Report Title: Antihemophilic Factor Market - Global Outlook and Forecast 2022-2028


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW